In addition, our understanding of the iron cycling imbalance and ferroptosis in the pathological context of bone and joint diseases is lacking
To your optimised, healthy future, Lulu & the Coho Health team How can we help you
After 104 weeks, semaglutide demonstrated noninferiority to placebo for the primary composite end point of the first occurrence of cardiovascular death, nonfatal MI, or nonfatal stroke (6.6 vs
[5] [6] This effect appears to be dose-dependent and duration-dependent, meaning higher doses and longer treatment periods increase the risk of deficiency
Current GLP1 drugs are given as injections (daily or weekly) or, more recently, as oral tablets
A blood test is available to provide genetic analysis